Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop

被引：4

作者：

Gavin, James R. ^{[1
]}

Rodbard, Helena W. ^{[2
]}

Battelino, Tadej ^{[3
,4
]}

Brosius, Frank ^{[5
]}

Ceriello, Antonio ^{[6
]}

Cosentino, Francesco ^{[7
,8
]}

Giorgino, Francesco ^{[9
,10
]}

Green, Jennifer ^{[11
]}

Ji, Linong ^{[12
]}

Kellerer, Monika ^{[13
]}

Koob, Susan ^{[11
,14
]}

Kosiborod, Mikhail ^{[12
,13
,15
,16
,17
,18
]}

Lalic, Nebojsa ^{[19
]}

Marx, Nikolaus ^{[20
]}

Nedungadi, T. Prashant ^{[21
]}

Parkin, Christopher G. ^{[22
]}

Topsever, Pinar ^{[23
]}

Ryden, Lars ^{[24
]}

Sheu, Wayne Huey-Herng ^{[25
]}

Standl, Eberhard ^{[26
]}

Vandvik, Per Olav ^{[27
]}

Schnell, Oliver ^{[26
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA USA

[2] Endocrine & Metab Consultants, 3200 Tower Oaks Blvd,Suite 250, Rockville, MD 20852 USA

[3] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[4] Univ Ljubljana, Fac Med, Ljubljana, Slovenia

[5] Univ Arizona, Coll Med, 1501 N Campbell Ave, Tucson, AZ 85724 USA

[6] IRCCS Multimed, Via Milanese 300, I-20099 Sesto San Giovanni, MI, Italy

[7] Karolinska Inst, Dept Med, Cardiol Unit, Solna, Stockholm, Sweden

[8] Karolinska Univ Hosp, Solna, Stockholm, Sweden

[9] Univ Bari Aldo Moro, Dept Precis & Regenerat Med, Bari, Italy

[10] Univ Bari Aldo Moro, Sect Internal Med Endocrinol Androl & Metab Dis, Ionian Area, Bari, Italy

[11] Duke Univ, Med Ctr, Duke Clin Res Inst, 641 Durham Ctr,Box 17969, Durham, NC 27715 USA

[12] Peking Univ Peoples Hosp, 11 Xizhimen S St, Beijing, Peoples R China

[13] Marienhosp Stuttgart, Boheimstr 37, D-70199 Stuttgart, Germany

[14] PCNA Natl Off, 613 Williamson St, Suite 200, Madison, WI 53703 USA

[15] St Lukes Mid Amer Heart Inst, 4401 Wornall Rd, Kansas City, MO 64111 USA

[16] Univ Missouri, 4401 Wornall Rd, Kansas City, MO 64111 USA

[17] George Inst Global Hlth, Sydney, Australia

[18] Univ New South Wales, Sydney, Australia

[19] Univ Belgrade, Univ Clin Ctr Serbia, Pasterova 2, Beograd 11000, Serbia

[20] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Internal Med 1, Pauwelsstr 30, D-52074 Aachen, Germany

[21] Amer Heart Assoc, 7272 Greenville Ave, Dallas, TX 75082 USA

[22] CGParkin Commun Inc, 2675 Windmill Pkwy,Suite 2721, Henderson, NV 89074 USA

[23] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Family Med, Kayisdagi Cd 3, TR-34752 Icerenkoy, Atasehir Istanb, Turkiye

[24] Karolinska Inst, Dept Med K2, Stockholm, Sweden

[25] Natl Res Hlth Inst, Inst Mol & Genom Med, Zhunan 350, Miaoli, Taiwan

[26] Forschergrp Diabet eV, Ingolstaedter Landstr 1, Munich, Germany

[27] Univ Oslo, Lovisenberg Diaconal Hosp, Inst Hlth & Soc, Dept Med, Lovisenberggata 17, N-0456 Oslo, Norway

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2024年 / 211卷

关键词：

Continuous glucose monitoring; CGM; Real-time CGM; rtCGM; Intermittently scanned CGM; isCGM; Type; 1; diabetes; 2; HbA1c; Ambulatory glucose profile; AGP; SELF-RATED HEALTH; QUALITY-OF-CARE; SOCIOECONOMIC-STATUS; STRUCTURAL RACISM; UNITED-STATES; ETHNIC DISPARITIES; HEART-FAILURE; IMPLICIT BIAS; PHYSICIANS; RISK;

D O I：

10.1016/j.diabres.2024.111666

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is a mounting clinical, psychosocial, and socioeconomic burden worldwide as the prevalence of diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD) continues to rise. Despite the introduction of therapeutic interventions with demonstrated efficacy to prevent the development or progression of these common chronic diseases, many individuals have limited access to these innovations due to their race/ethnicity, and/ or socioeconomic status (SES). However, practical guidance to providers and healthcare systems for addressing these disparities is often lacking. In this article, we review the prevalence and impact of healthcare disparities derived from the above-mentioned chronic conditions and present broad-based recommendations for improving access to quality care and health outcomes within the most vulnerable populations.

引用

页数：7

共 50 条

[1] Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases
Marx, Nikolaus
Ryden, Lars
Brosius, Frank
Ceriello, Antonio
Cheung, Michael
Cosentino, Francesco
Green, Jennifer
Kellerer, Monika
Koob, Susan
Kosiborod, Mikhail
Nedungadi, Prashant
Rodbard, Helena W.
Vandvik, Per Olav
Standl, Eberhard
Schnell, Oliver
DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (07) : 546 - 552
[2] Proceedings of the Guideline Workshop 2019 Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases
Marx, Nikolaus
Ryden, Lars
Brosius, Frank
Ceriello, Antonio
Cheung, Michael
Cosentino, Francesco
Green, Jennifer
Kellerer, Monika
Koob, Susan
Kosiborod, Mikhail
Nedungadi, Prashant
Rodbard, Helena W.
Vandvik, Per Olav
Standl, Eberhard
Schnell, Oliver
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
[3] Proceedings of the Guideline Workshop 2019-Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases
Marx, N.
Ryden, L.
Brosius, F.
Ceriello, A.
Cheung, M.
Cosentino, F.
Green, J.
Kellerer, M.
Koob, S.
Kosiborod, M.
Nedungadi, P.
Rodbard, H. W.
Vandvik, P. O.
Standl, E.
Schnell, O.
DIABETES STOFFWECHSEL UND HERZ, 2020, 29 (03): : 164 - 170
[4] Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop
Barnard-Kelly, Katharine
Battelino, Tadej
Brosius, Frank C.
Ceriello, Antonio
Cosentino, Francesco
Gavin III, James R.
Giorgino, Francesco
Green, Jennifer
Ji, Linong
Kellerer, Monika
Koob, Sue
Kosiborod, Mikhail
Lalic, Nebojsa
Marx, Nikolaus
Nedungadi, Prashant
Parkin, Christopher G.
Rodbard, Helena W.
Roetzer, Rene D.
Ryden, Lars
Sheu, Wayne Huey-Herng
Standl, Eberhard
Jeppesen, Britta Tendal
Topsever, Pinar
Vandvik, Per Olav
Wanner, Christoph
Schnell, Oliver
CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
[5] The Compatibility of the Treatment Modalities to the Recommendations of the Kidney Disease Outcomes Quality Initiative Guideline in Chronic Kidney Disease Patients with Diabetes
Adibelli, Zelal
Duran, Cevdet
IRANIAN JOURNAL OF PUBLIC HEALTH, 2021, 50 (06) : 1206 - 1212
[6] The Prevalence of Traditional Cardiovascular Risk Factors in Patients with Chronic Rheumatic Diseases and Adherence with Treatment Recommendations
Jacobson, Micaela
Akhtari, Shadi
Harvey, Paula
Jerome, Dana
Hochman, Jacqueline
Grigoriadis, Elizabeth
Gakhal, Natasha
Eder, Lihi
JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1022 - 1023
[7] Limitations in international Studies on cardiovascular Diseases and chronic Renal Failure - Consideration in Guideline Recommendations
Djuric, Ivona
Gockel, Lukas
Preukschat, Daniela
Kranz, Philip
INNERE MEDIZIN, 2024, 65 : S146 - S147
[8] Prevention of cardiovascular diseases, diabetes mellitus and chronic kidney diseases in general practice
Nielen, M.
Assendelft, P.
Drenthen, T.
van den Hombergh, P.
van Dis, I
Schellevis, F.
SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 20S - 20S
[9] Chronic kidney diseases in agricultural communities: report from a workshop
Mendley, Susan R.
Levin, Adeera
Correa-Rotter, Ricardo
Joubert, Bonnie R.
Whelan, Elizabeth A.
Curwin, Brian
Koritzinsky, Erik H.
Gaughan, Denise M.
Kimmel, Paul L.
Anand, Shuchi
Ordunez, Pedro
Reveiz, Ludovic
Rohlman, Diane S.
Scammell, Madeleine K.
Wright, Robert O.
Star, Robert A.
KIDNEY INTERNATIONAL, 2019, 96 (05) : 1071 - 1076
[10] Treatment of chronic hepatitis B: Recommendations from an Italian workshop
Carosi, G.
Rizzetto, M.
DIGESTIVE AND LIVER DISEASE, 2008, 40 (08) : 603 - 617

← 1 2 3 4 5 →